This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Jane C. Dale, MD; Peter Wollan, PhD; Frank R. Cockerill III, MD
Mayo Clinic Rochester, Minn

JAMA. 1997;278(1):23.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—In the article by Dr Gerber and colleagues¹ reporting an office-based multicenter investigation of the optical immunoassay (OIA) test for group A β-hemolytic streptococcal (GABHS) pharyngitis, the authors concluded that "with adequately trained personnel, negative OIA test results may not always need to be routinely confirmed with blood agar plate (BAP) cultures." We believe the authors' conclusions are based less on the quality of the testing personnel or the performance specifications of the OIA and more on the quality of the BAP culture procedure used in the study.

Presumptive differentiation of GABHS and non—group A streptococci may be accomplished by the bacitracin test, in which a zone of inhibition is noted on a pure subculture of β-hemolytic colonies. Bacitracin disks placed on primary cultures on nonselective media, as was done in this study, may detect as little as 54% of group A streptococci.² We compared . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?